Projects per year
Personal profile
Education
- 1982 Taipei Medical College, M.D.
Research Interests
- Hepatitis
- Hepatocellular Carcinoma
- Virology
Experience
- 1990/8~1993/7 Instructor of Medicine, Medical College, National Cheng Kung University (NCKU)
- 1993/8~1996/7 Associate Professor, Medical College, National Cheng Kung University (NCKU)
- 1996/8~present Professor of Medicine, Medical College, National Cheng Kung University (NCKU)
- 1998/8~2000/7 Secretary of Medical Affairs, National Cheng Kung University Hospital (NCKUH)
- 2000/8~2002/7 Director, Department of Clinical Medicine, National Cheng Kung University Hospital (NCKUH)
- 2000/8~2004/7 Director, Institute of Molecular Medicine, Medical College, National Cheng Kung University (NCKU)
- 2000/8~2004/7 Chief, Division of Gastroenterology, National Cheng Kung University Hospital (NCKUH)
- 2003~present Director, Biotechnologic Center of Hepatology, Research and Services Headquarter of National Cheng Kung University
- 2006~present Distinguished Professor of Internal Medicine, Medical College, NCKU
- 2013/8~2017/7 Associate Director, Medical College, National Cheng Kung University Hospital (NCKUH)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Ting-Tsung Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 40 Finished
-
Clinical characteristics and outcomes of drug-induced liver injury in Taiwan: With emphasis on the impact of chronic hepatitis B infection
Huang, Y. S., Tseng, S. Y., Chen, W. W., Chang, T. T., Peng, C. Y., Lo, G. H., Hsu, C. W., Hu, C. T. & Huang, Y. H., 2022 Mar 1, In: Journal of the Chinese Medical Association. 85, 3, p. 286-294 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Tseng, C. W., Liu, W. C., Chen, C. Y., Chang, T. T. & Tseng, K. C., 2022 Dec, In: BMC infectious diseases. 22, 1, 351.Research output: Contribution to journal › Article › peer-review
Open Access -
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
Liu, C. J., Sheen, I. S., Chen, C. Y., Chuang, W. L., Wang, H. Y., Tseng, K. C., Chang, T. T., Yang, J., Massetto, B., Suri, V., Camus, G., Jiang, D., Zhang, F., Gaggar, A., Hu, T. H., Hsu, Y. C., Lo, G. H., Chu, C. J., Chen, J. J., Peng, C. Y., & 2 others, 2022 Aug 31, In: Clinical Infectious Diseases. 75, 3, p. 453-459 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
Kuo, H. Y., Han, M. Z., Liao, C. H., Lin, Y. J., Wang, C. T., Chen, S. H., Chang, T. T., Chen, P. J., Lin, S. H., Chen, C. Y., Chuang, C. H., Wu, I. C., Wu, J. S., Hong, T. C., Hsieh, M. T., Lee, Y. C., Wu, H. T. & Tsai, H. M., 2022 Nov, In: Pharmaceutics. 14, 11, 2263.Research output: Contribution to journal › Article › peer-review
Open Access -
The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
Tseng, C. W., Liu, W-C., Ko, P. H., Chen, Y. C., Tseng, K. C. & Chang, T. T., 2022 Aug, In: Viruses. 14, 8, 1812.Research output: Contribution to journal › Article › peer-review
Open Access